Tetraphase’s (NASDAQ:TTPH) Auryxia just won the Food and Drug Administration (FDA) green light for treating patients with complicated Intra-Abdominal Infections (cIAI), but Needham’s Alan Carr believes …
Tetraphase (NASDAQ:TTPH) investors are scratching their heads today as to why the stock is falling 8% following the announcement of FDA approval for …
H.C.
Small biotech stocks are often considered “binary” lottery-ticket type events, with either a small chance of big upside, or a much greater probability …
Tetraphase Pharmaceuticals Inc (NASDAQ:TTPH) shares are jumping up close to 16% after the drug maker released top-line data from its Phase 3 study …
Tetraphase Pharmaceuticals Inc (NASDAQ:TTPH) had a rough day today as shares fell 17%, after the antibiotic drug-maker announced that the FDA is requiring …
Recently, various executives have taken part in insider selling activity for the stocks of GoPro Inc (NASDAQ:GPRO), Twitter Inc (NYSE:TWTR), Tetraphase Pharmaceuticals Inc (NASDAQ:TTPH), and Clean …
Roth Capital’s healthcare analyst Debjit Chattopadhyay weighed in today with his views on Cempra Inc (NASDAQ:CEMP), following the news that Tetraphase Pharmaceuticals Inc (NASDAQ:TTPH)’s IGNITE2 phase …
There has been a lot of action on Wall Street today as analysts have weighed in on their favorite stocks. Below are the …
MannKind Corporation (NASDAQ:MNKD) fell 10.07% in pre-market trading to $3.
